Nath Bio-Genes (India) Limited

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, COROMANDEL.BO has a market cap of 564.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while COROMANDEL.BO trades at ₹1,972.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas COROMANDEL.BO's P/E ratio is 23.55. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to COROMANDEL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to COROMANDEL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check COROMANDEL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, COROMANDEL.NS has a market cap of 563.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while COROMANDEL.NS trades at ₹1,973.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas COROMANDEL.NS's P/E ratio is 23.54. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to COROMANDEL.NS's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to COROMANDEL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check COROMANDEL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, UPL.NS has a market cap of 528.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while UPL.NS trades at ₹611.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas UPL.NS's P/E ratio is 29.83. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to UPL.NS's ROE of +0.05%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to UPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check UPL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, FACT.BO has a market cap of 512.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while FACT.BO trades at ₹788.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas FACT.BO's P/E ratio is 1684.15. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to FACT.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to FACT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check FACT.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, FACT.NS has a market cap of 512.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while FACT.NS trades at ₹787.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas FACT.NS's P/E ratio is 1930.37. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to FACT.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to FACT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check FACT.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, PIIND.NS has a market cap of 441.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while PIIND.NS trades at ₹2,890.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas PIIND.NS's P/E ratio is 30.41. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PIIND.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PIIND.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PIIND.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, PIIND.BO has a market cap of 441.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while PIIND.BO trades at ₹2,892.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas PIIND.BO's P/E ratio is 30.37. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PIIND.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PIIND.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PIIND.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BAYERCROP.NS has a market cap of 212B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BAYERCROP.NS trades at ₹4,468.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BAYERCROP.NS's P/E ratio is 31.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BAYERCROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BAYERCROP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BAYERCROP.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SUMICHEM.BO has a market cap of 193.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SUMICHEM.BO trades at ₹384.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SUMICHEM.BO's P/E ratio is 36.38. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SUMICHEM.BO's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SUMICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SUMICHEM.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SUMICHEM.NS has a market cap of 193.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SUMICHEM.NS trades at ₹382.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SUMICHEM.NS's P/E ratio is 36.41. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SUMICHEM.NS's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SUMICHEM.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SUMICHEM.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, ATUL7.BO has a market cap of 179B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while ATUL7.BO trades at ₹7,100.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas ATUL7.BO's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ATUL7.BO's ROE of +0.10%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ATUL7.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ATUL7.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, CHAMBLFERT.BO has a market cap of 171.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while CHAMBLFERT.BO trades at ₹426.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas CHAMBLFERT.BO's P/E ratio is 9.23. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CHAMBLFERT.BO's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to CHAMBLFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CHAMBLFERT.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, CHAMBLFERT.NS has a market cap of 171.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while CHAMBLFERT.NS trades at ₹426.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas CHAMBLFERT.NS's P/E ratio is 8.97. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CHAMBLFERT.NS's ROE of +0.22%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to CHAMBLFERT.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CHAMBLFERT.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, EIDPARRY.BO has a market cap of 140.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while EIDPARRY.BO trades at ₹796.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas EIDPARRY.BO's P/E ratio is 12.20. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EIDPARRY.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to EIDPARRY.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EIDPARRY.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, PARADEEP.BO has a market cap of 90.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while PARADEEP.BO trades at ₹113.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas PARADEEP.BO's P/E ratio is 10.93. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PARADEEP.BO's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PARADEEP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PARADEEP.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, PARADEEP.NS has a market cap of 90.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while PARADEEP.NS trades at ₹113.13.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas PARADEEP.NS's P/E ratio is 10.92. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PARADEEP.NS's ROE of +0.20%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PARADEEP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PARADEEP.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SHARDACROP.NS has a market cap of 88.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SHARDACROP.NS trades at ₹958.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SHARDACROP.NS's P/E ratio is 15.61. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHARDACROP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SHARDACROP.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHARDACROP.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SHARDACROP.BO has a market cap of 88.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SHARDACROP.BO trades at ₹960.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SHARDACROP.BO's P/E ratio is 15.59. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHARDACROP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SHARDACROP.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHARDACROP.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RCF.BO has a market cap of 64.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RCF.BO trades at ₹115.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RCF.BO's P/E ratio is 20.59. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RCF.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RCF.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RCF.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RCF.NS has a market cap of 64.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RCF.NS trades at ₹115.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RCF.NS's P/E ratio is 20.57. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RCF.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RCF.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RCF.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, GSFC.BO has a market cap of 61.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while GSFC.BO trades at ₹155.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas GSFC.BO's P/E ratio is 9.19. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GSFC.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to GSFC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GSFC.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, GSFC.NS has a market cap of 61.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while GSFC.NS trades at ₹155.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas GSFC.NS's P/E ratio is 8.85. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GSFC.NS's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to GSFC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GSFC.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, PICCADIL.BO has a market cap of 53.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while PICCADIL.BO trades at ₹540.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas PICCADIL.BO's P/E ratio is 39.17. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to PICCADIL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to PICCADIL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check PICCADIL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RALLIS.NS has a market cap of 46.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RALLIS.NS trades at ₹242.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RALLIS.NS's P/E ratio is 27.78. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RALLIS.NS's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RALLIS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RALLIS.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RALLIS.BO has a market cap of 46.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RALLIS.BO trades at ₹242.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RALLIS.BO's P/E ratio is 27.74. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RALLIS.BO's ROE of +0.09%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RALLIS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RALLIS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, DHANUKA.NS has a market cap of 43.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while DHANUKA.NS trades at ₹971.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas DHANUKA.NS's P/E ratio is 6.15. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHANUKA.NS's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to DHANUKA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHANUKA.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, DHANUKA.BO has a market cap of 43.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while DHANUKA.BO trades at ₹974.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas DHANUKA.BO's P/E ratio is 6.14. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHANUKA.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to DHANUKA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHANUKA.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KSCL.BO has a market cap of 41.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KSCL.BO trades at ₹766.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KSCL.BO's P/E ratio is 13.80. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSCL.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSCL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSCL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MBAPL.NS has a market cap of 39.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MBAPL.NS trades at ₹437.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MBAPL.NS's P/E ratio is 37.91. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MBAPL.NS's ROE of +0.26%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MBAPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MBAPL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MANGCHEFER.NS has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MANGCHEFER.NS trades at ₹308.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MANGCHEFER.NS's P/E ratio is 22.67. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MANGCHEFER.NS's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MANGCHEFER.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MANGCHEFER.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MANGCHEFER.BO has a market cap of 36.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MANGCHEFER.BO trades at ₹308.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MANGCHEFER.BO's P/E ratio is 22.63. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MANGCHEFER.BO's ROE of +0.16%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MANGCHEFER.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MANGCHEFER.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BNHOLDINGS.BO has a market cap of 34.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BNHOLDINGS.BO trades at ₹355.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BNHOLDINGS.BO's P/E ratio is 26.71. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BNHOLDINGS.BO's ROE of +0.18%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BNHOLDINGS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BNHOLDINGS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NFL.NS has a market cap of 34B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NFL.NS trades at ₹68.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NFL.NS's P/E ratio is 17.48. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NFL.NS's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NFL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NFL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NFL.BO has a market cap of 34B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NFL.BO trades at ₹68.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NFL.BO's P/E ratio is 17.45. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NFL.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NFL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NFL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KRISHANA.NS has a market cap of 30.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KRISHANA.NS trades at ₹475.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KRISHANA.NS's P/E ratio is 23.16. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KRISHANA.NS's ROE of +0.34%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KRISHANA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KRISHANA.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, CIANAGRO.BO has a market cap of 27.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while CIANAGRO.BO trades at ₹1,020.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas CIANAGRO.BO's P/E ratio is 24.17. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to CIANAGRO.BO's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to CIANAGRO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check CIANAGRO.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NACLIND.NS has a market cap of 27.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NACLIND.NS trades at ₹132.69.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NACLIND.NS's P/E ratio is -67.98. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NACLIND.NS's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NACLIND.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NACLIND.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NACLIND.BO has a market cap of 26.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NACLIND.BO trades at ₹132.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NACLIND.BO's P/E ratio is -67.59. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NACLIND.BO's ROE of -0.10%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NACLIND.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NACLIND.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, VENKYS.BO has a market cap of 24.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while VENKYS.BO trades at ₹1,714.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas VENKYS.BO's P/E ratio is -57.49. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to VENKYS.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to VENKYS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check VENKYS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BHAGCHEM.NS has a market cap of 23.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BHAGCHEM.NS trades at ₹182.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BHAGCHEM.NS's P/E ratio is 176.89. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHAGCHEM.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BHAGCHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHAGCHEM.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BHAGCHEM.BO has a market cap of 23.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BHAGCHEM.BO trades at ₹182.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BHAGCHEM.BO's P/E ratio is 176.62. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHAGCHEM.BO's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHAGCHEM.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHAGCHEM.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KSE.NS has a market cap of 22.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KSE.NS trades at ₹697.65.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KSE.NS's P/E ratio is N/A. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSE.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSE.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSE.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, INSECTICID.BO has a market cap of 16.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while INSECTICID.BO trades at ₹568.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas INSECTICID.BO's P/E ratio is 11.80. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INSECTICID.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to INSECTICID.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INSECTICID.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, INSECTICID.NS has a market cap of 16.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while INSECTICID.NS trades at ₹567.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas INSECTICID.NS's P/E ratio is 11.79. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INSECTICID.NS's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to INSECTICID.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INSECTICID.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, IPL.BO has a market cap of 15.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while IPL.BO trades at ₹135.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas IPL.BO's P/E ratio is 14.42. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IPL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to IPL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IPL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, IPL.NS has a market cap of 15.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while IPL.NS trades at ₹135.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas IPL.NS's P/E ratio is 14.42. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IPL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to IPL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IPL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SPIC.BO has a market cap of 12.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SPIC.BO trades at ₹60.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SPIC.BO's P/E ratio is 6.76. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPIC.BO's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SPIC.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPIC.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, ASTEC.NS has a market cap of 12.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while ASTEC.NS trades at ₹564.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas ASTEC.NS's P/E ratio is -13.30. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ASTEC.NS's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to ASTEC.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ASTEC.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SPIC.NS has a market cap of 12.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SPIC.NS trades at ₹60.84.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SPIC.NS's P/E ratio is 6.21. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPIC.NS's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SPIC.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPIC.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, ASTEC.BO has a market cap of 12.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while ASTEC.BO trades at ₹565.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas ASTEC.BO's P/E ratio is -13.26. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ASTEC.BO's ROE of -0.30%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to ASTEC.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ASTEC.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MOL.NS has a market cap of 10.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MOL.NS trades at ₹42.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MOL.NS's P/E ratio is 26.81. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MOL.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MOL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MOL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MOL.BO has a market cap of 10.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MOL.BO trades at ₹42.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MOL.BO's P/E ratio is 26.75. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MOL.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MOL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MOL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BHARATRAS.BO has a market cap of 10.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BHARATRAS.BO trades at ₹1,274.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BHARATRAS.BO's P/E ratio is 15.92. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATRAS.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHARATRAS.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATRAS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BHARATRAS.NS has a market cap of 10.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BHARATRAS.NS trades at ₹1,273.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BHARATRAS.NS's P/E ratio is 15.97. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATRAS.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BHARATRAS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATRAS.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MADRASFERT.BO has a market cap of 9.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MADRASFERT.BO trades at ₹60.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MADRASFERT.BO's P/E ratio is 135.56. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MADRASFERT.BO's ROE of -0.31%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MADRASFERT.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MADRASFERT.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MADRASFERT.NS has a market cap of 9.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MADRASFERT.NS trades at ₹60.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MADRASFERT.NS's P/E ratio is 134.80. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MADRASFERT.NS's ROE of -0.31%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to MADRASFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MADRASFERT.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BLUECLOUDS.BO has a market cap of 8.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BLUECLOUDS.BO trades at ₹19.28.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BLUECLOUDS.BO's P/E ratio is 14.24. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BLUECLOUDS.BO's ROE of +0.49%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BLUECLOUDS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BLUECLOUDS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, ZUARI.NS has a market cap of 8.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while ZUARI.NS trades at ₹196.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas ZUARI.NS's P/E ratio is 0.86. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ZUARI.NS's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ZUARI.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ZUARI.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BSHSL.NS has a market cap of 8.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BSHSL.NS trades at ₹79.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BSHSL.NS's P/E ratio is 29.26. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BSHSL.NS's ROE of +0.25%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BSHSL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BSHSL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, DHARMAJ.NS has a market cap of 8.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while DHARMAJ.NS trades at ₹237.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas DHARMAJ.NS's P/E ratio is 16.84. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHARMAJ.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to DHARMAJ.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHARMAJ.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, DHARMAJ.BO has a market cap of 8.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while DHARMAJ.BO trades at ₹236.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas DHARMAJ.BO's P/E ratio is 16.77. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to DHARMAJ.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to DHARMAJ.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check DHARMAJ.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BAJAJST.BO has a market cap of 7.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BAJAJST.BO trades at ₹371.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BAJAJST.BO's P/E ratio is 15.08. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BAJAJST.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BAJAJST.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BAJAJST.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, HERANBA.NS has a market cap of 7.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while HERANBA.NS trades at ₹170.92.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas HERANBA.NS's P/E ratio is -11.94. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to HERANBA.NS's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to HERANBA.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check HERANBA.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, HERANBA.BO has a market cap of 7.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while HERANBA.BO trades at ₹170.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas HERANBA.BO's P/E ratio is -11.92. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to HERANBA.BO's ROE of -0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to HERANBA.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check HERANBA.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KSE.BO has a market cap of 6.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KSE.BO trades at ₹190.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KSE.BO's P/E ratio is 5.00. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KSE.BO's ROE of +0.41%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KSE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KSE.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SVRL.BO has a market cap of 6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SVRL.BO trades at ₹261.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SVRL.BO's P/E ratio is 23.69. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SVRL.BO's ROE of +0.21%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SVRL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SVRL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SHINDL.BO has a market cap of 5.8B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SHINDL.BO trades at ₹145.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SHINDL.BO's P/E ratio is 46.75. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHINDL.BO's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SHINDL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHINDL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BESTAGRO.NS has a market cap of 5.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BESTAGRO.NS trades at ₹14.41.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BESTAGRO.NS's P/E ratio is 7.71. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BESTAGRO.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BESTAGRO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BESTAGRO.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BESTAGRO.BO has a market cap of 5.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BESTAGRO.BO trades at ₹14.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BESTAGRO.BO's P/E ratio is 7.64. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BESTAGRO.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to BESTAGRO.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BESTAGRO.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KHAICHEM.BO has a market cap of 4.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KHAICHEM.BO trades at ₹48.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KHAICHEM.BO's P/E ratio is 6.59. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KHAICHEM.BO's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KHAICHEM.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KHAICHEM.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KHAICHEM.NS has a market cap of 4.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KHAICHEM.NS trades at ₹48.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KHAICHEM.NS's P/E ratio is 6.58. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KHAICHEM.NS's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KHAICHEM.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KHAICHEM.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, ARIES.NS has a market cap of 4.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while ARIES.NS trades at ₹331.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas ARIES.NS's P/E ratio is 10.11. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to ARIES.NS's ROE of +0.15%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to ARIES.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check ARIES.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KNAGRI.NS has a market cap of 4.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KNAGRI.NS trades at ₹177.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KNAGRI.NS's P/E ratio is 11.66. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KNAGRI.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to KNAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KNAGRI.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MISHTANN.BO has a market cap of 4.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MISHTANN.BO trades at ₹3.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MISHTANN.BO's P/E ratio is 1.25. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MISHTANN.BO's ROE of +0.35%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MISHTANN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MISHTANN.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RAMAPHO.BO has a market cap of 4.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RAMAPHO.BO trades at ₹111.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RAMAPHO.BO's P/E ratio is 7.81. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RAMAPHO.BO's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to RAMAPHO.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RAMAPHO.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RAMAPHO.NS has a market cap of 4.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RAMAPHO.NS trades at ₹112.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RAMAPHO.NS's P/E ratio is 7.79. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RAMAPHO.NS's ROE of +0.14%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RAMAPHO.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RAMAPHO.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MODINATUR.BO has a market cap of 4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MODINATUR.BO trades at ₹287.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MODINATUR.BO's P/E ratio is 10.43. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MODINATUR.BO's ROE of +0.32%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MODINATUR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MODINATUR.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, IGCL.NS has a market cap of 3.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while IGCL.NS trades at ₹56.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas IGCL.NS's P/E ratio is 10.72. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to IGCL.NS's ROE of +0.12%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to IGCL.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check IGCL.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SHIVALIK.NS has a market cap of 3.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SHIVALIK.NS trades at ₹241.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SHIVALIK.NS's P/E ratio is 31.80. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SHIVALIK.NS's ROE of +0.02%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SHIVALIK.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SHIVALIK.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, GOODRICKE.BO has a market cap of 3.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while GOODRICKE.BO trades at ₹148.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas GOODRICKE.BO's P/E ratio is 18.05. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to GOODRICKE.BO's ROE of +0.06%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to GOODRICKE.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check GOODRICKE.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NATHBIOGEN.BO has a market cap of 2.7B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NATHBIOGEN.BO trades at ₹139.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NATHBIOGEN.BO's P/E ratio is 6.17. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NATHBIOGEN.BO's ROE of +0.07%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to NATHBIOGEN.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NATHBIOGEN.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, KINGSINFR.BO has a market cap of 2.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while KINGSINFR.BO trades at ₹110.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas KINGSINFR.BO's P/E ratio is 19.37. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to KINGSINFR.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to KINGSINFR.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check KINGSINFR.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NAGAFERT.NS has a market cap of 2.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NAGAFERT.NS trades at ₹3.93.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NAGAFERT.NS's P/E ratio is -8.63. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NAGAFERT.NS's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NAGAFERT.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NAGAFERT.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NAGAFERT.BO has a market cap of 2.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NAGAFERT.BO trades at ₹3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NAGAFERT.BO's P/E ratio is -8.52. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NAGAFERT.BO's ROE of +0.03%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NAGAFERT.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NAGAFERT.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, INDOUS.BO has a market cap of 2.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while INDOUS.BO trades at ₹103.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas INDOUS.BO's P/E ratio is 14.19. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDOUS.BO's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDOUS.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDOUS.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, INDOUS.NS has a market cap of 2.1B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while INDOUS.NS trades at ₹103.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas INDOUS.NS's P/E ratio is 14.08. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDOUS.NS's ROE of +0.19%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDOUS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDOUS.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NOVAAGRI.NS has a market cap of 2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NOVAAGRI.NS trades at ₹25.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NOVAAGRI.NS's P/E ratio is 11.83. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NOVAAGRI.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NOVAAGRI.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NOVAAGRI.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, RBS.NS has a market cap of 1.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while RBS.NS trades at ₹78.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas RBS.NS's P/E ratio is 11.89. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to RBS.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to RBS.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check RBS.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, EQUIPPP.BO has a market cap of 1.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while EQUIPPP.BO trades at ₹18.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas EQUIPPP.BO's P/E ratio is 257.14. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EQUIPPP.BO's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to EQUIPPP.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EQUIPPP.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, EQUIPPP.NS has a market cap of 1.9B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while EQUIPPP.NS trades at ₹18.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas EQUIPPP.NS's P/E ratio is 256.57. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to EQUIPPP.NS's ROE of +0.23%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to EQUIPPP.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check EQUIPPP.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, HOACFOODS.NS has a market cap of 1.6B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while HOACFOODS.NS trades at ₹354.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas HOACFOODS.NS's P/E ratio is 53.35. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to HOACFOODS.NS's ROE of N/A. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to HOACFOODS.NS. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check HOACFOODS.NS's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, VIJSOLX.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while VIJSOLX.BO trades at ₹482.05.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas VIJSOLX.BO's P/E ratio is 10.10. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to VIJSOLX.BO's ROE of +0.04%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to VIJSOLX.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check VIJSOLX.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SBECSUG.BO has a market cap of 1.5B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SBECSUG.BO trades at ₹30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SBECSUG.BO's P/E ratio is -5.78. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SBECSUG.BO's ROE of +0.33%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SBECSUG.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SBECSUG.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SPTRSHI.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SPTRSHI.BO trades at ₹43.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SPTRSHI.BO's P/E ratio is 46.47. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SPTRSHI.BO's ROE of +0.25%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to SPTRSHI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SPTRSHI.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, MSL.BO has a market cap of 1.4B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while MSL.BO trades at ₹133.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas MSL.BO's P/E ratio is 13.50. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to MSL.BO's ROE of +0.13%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to MSL.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check MSL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, BHARATAGRI.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while BHARATAGRI.BO trades at ₹24.63.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas BHARATAGRI.BO's P/E ratio is -63.82. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to BHARATAGRI.BO's ROE of -0.04%. Regarding short-term risk, NATHBIOGEN.NS is more volatile compared to BHARATAGRI.BO. This indicates potentially higher risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check BHARATAGRI.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, SSLEL.BO has a market cap of 1.3B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while SSLEL.BO trades at ₹244.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas SSLEL.BO's P/E ratio is -5.40. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to SSLEL.BO's ROE of +0.11%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to SSLEL.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check SSLEL.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, INDSUCR.BO has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while INDSUCR.BO trades at ₹70.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas INDSUCR.BO's P/E ratio is 3.02. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to INDSUCR.BO's ROE of +0.17%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to INDSUCR.BO. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check INDSUCR.BO's competition here

NATHBIOGEN.NS plays a significant role within the Basic Materials sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, NATHBIOGEN.NS stands at 2.7B. In comparison, NARMADA.NS has a market cap of 1.2B. Regarding current trading prices, NATHBIOGEN.NS is priced at ₹139.53, while NARMADA.NS trades at ₹31.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

NATHBIOGEN.NS currently has a P/E ratio of 6.16, whereas NARMADA.NS's P/E ratio is 29.28. In terms of profitability, NATHBIOGEN.NS's ROE is +0.07%, compared to NARMADA.NS's ROE of +0.08%. Regarding short-term risk, NATHBIOGEN.NS is less volatile compared to NARMADA.NS. This indicates potentially lower risk in terms of short-term price fluctuations for NATHBIOGEN.NS.Check NARMADA.NS's competition here